We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Emerson Electric Co. (EMR - Free Report) is benefiting from the persistent strength in its Intelligent Devices segment. Within the segment, the company is witnessing solid momentum in the Final Control business, supported by a strong demand environment across power end markets. Sales from this business increased 4% year over year in fiscal 2025 (ended September 2025).
Robust growth across the Americas and Asia, the Middle East & Africa regions is aiding Emerson’s Measurement & Analytical business. Sales from the business rose 2% year over year in the fiscal year. The Discrete Automation business’ sales increased 1% year over year in fiscal 2025, driven by solid momentum in the Americas region. However, softness in the Safety & Productivity business, owing to tepid demand for its products, remains concerning. Sales from the business declined 2% in the fiscal year.
Apart from this, EMR’s Software and Control segment is well positioned to benefit from solid growth in its AspenTech unit and strength in the power and process end markets. Given the strength across the majority of its businesses, Emerson expects net sales to increase approximately 5.5% year over year in fiscal 2026 (ended September 2026). Underlying sales are also anticipated to grow about 4% year over year in the same period.
Segment Snapshot of EMR’s Peers
As one of Emerson’s peers, Ingersoll Rand Inc. (IR - Free Report) is benefiting from strong orders across its product portfolio of industrial vacuums, blowers and compressors, which drove Ingersoll's Industrial Technologies & Services segment. The segment’s revenues totaled $1.54 billion, up 5% year over year in the third quarter of 2025.
Another peer, Flowserve Corp. (FLS - Free Report) is experiencing strength in the Pump Division segment. Strength in the aftermarket business, driven by a strong demand for products and services, is a prime catalyst for the Flowserve Pump Division segment’s growth. Its revenues totaled $800.3 million in the third quarter of 2025, up 2.3% year over year.
EMR’s Price Performance, Valuation and Estimates
Shares of Emerson have gained 1.8% in the past three months compared with the industry’s growth of 0.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, EMR is trading at a forward price-to-earnings ratio of 20.14X, below the industry’s average of 21.68X. Emerson carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for EMR’s fiscal 2026 earnings has inched down 0.3% over the past 60 days.
Image: Bigstock
Intelligent Devices Segment Drives Emerson: Can the Momentum Sustain?
Key Takeaways
Emerson Electric Co. (EMR - Free Report) is benefiting from the persistent strength in its Intelligent Devices segment. Within the segment, the company is witnessing solid momentum in the Final Control business, supported by a strong demand environment across power end markets. Sales from this business increased 4% year over year in fiscal 2025 (ended September 2025).
Robust growth across the Americas and Asia, the Middle East & Africa regions is aiding Emerson’s Measurement & Analytical business. Sales from the business rose 2% year over year in the fiscal year. The Discrete Automation business’ sales increased 1% year over year in fiscal 2025, driven by solid momentum in the Americas region. However, softness in the Safety & Productivity business, owing to tepid demand for its products, remains concerning. Sales from the business declined 2% in the fiscal year.
Apart from this, EMR’s Software and Control segment is well positioned to benefit from solid growth in its AspenTech unit and strength in the power and process end markets. Given the strength across the majority of its businesses, Emerson expects net sales to increase approximately 5.5% year over year in fiscal 2026 (ended September 2026). Underlying sales are also anticipated to grow about 4% year over year in the same period.
Segment Snapshot of EMR’s Peers
As one of Emerson’s peers, Ingersoll Rand Inc. (IR - Free Report) is benefiting from strong orders across its product portfolio of industrial vacuums, blowers and compressors, which drove Ingersoll's Industrial Technologies & Services segment. The segment’s revenues totaled $1.54 billion, up 5% year over year in the third quarter of 2025.
Another peer, Flowserve Corp. (FLS - Free Report) is experiencing strength in the Pump Division segment. Strength in the aftermarket business, driven by a strong demand for products and services, is a prime catalyst for the Flowserve Pump Division segment’s growth. Its revenues totaled $800.3 million in the third quarter of 2025, up 2.3% year over year.
EMR’s Price Performance, Valuation and Estimates
Shares of Emerson have gained 1.8% in the past three months compared with the industry’s growth of 0.6%.
Image Source: Zacks Investment Research
From a valuation standpoint, EMR is trading at a forward price-to-earnings ratio of 20.14X, below the industry’s average of 21.68X. Emerson carries a Value Score of D.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for EMR’s fiscal 2026 earnings has inched down 0.3% over the past 60 days.
Image Source: Zacks Investment Research
Emerson currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.